Vivos Inc. (RDGL)
OTCMKTS · Delayed Price · Currency is USD
0.0653
-0.0037 (-5.36%)
May 29, 2026, 3:39 PM EST
Vivos Market Cap
Vivos has a market cap or net worth of $34.06 million as of May 29, 2026. Its market cap has decreased by -44.37% in one year.
Market Cap
34.06M
Enterprise Value
40.99M
Revenue
77.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since September 1, 1998, Vivos's market cap has increased from 12.08M to 34.06M, an increase of 181.89%. That is a compound annual growth rate of 3.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 34.06M | 8.61% |
| Dec 31, 2025 | 31.36M | -37.86% |
| Dec 31, 2024 | 50.47M | 81.66% |
| Dec 29, 2023 | 27.78M | 73.14% |
| Dec 30, 2022 | 16.05M | -44.73% |
| Dec 31, 2021 | 29.03M | -5.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zomedica | 101.91M |
| RetinalGenix Technologies | 75.02M |
| Positron | 60.77M |
| Family Office of America | 36.42M |
| PetVivo Holdings | 28.77M |
| Guided Therapeutics | 18.34M |
| CS Diagnostics | 15.57M |
| Allurion Technologies | 12.01M |